Maintenance Hormone Therapy with Letrozole after First-Line Chemotherapy for Advanced Breast Cancer

Publisher： Karger

E-ISSN： 1423-0232|68|4-6|364-370

ISSN： 0030-2414

Source： Oncology, Vol.68, Iss.4-6, 2005-08, pp. : 364-370

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gemcitabine plus Paclitaxel as First-Line Chemotherapy for Patients with Advanced Breast Cancer

By  

Oncology, Vol. 66, Iss. 1, 2004-03 ,pp. : 18-23

Karger

Access to resources Recommend Favorite

First-Line Chemotherapy with Vinorelbine and Paclitaxel as Simultaneous Infusion in Advanced Breast Cancer

By  

Oncology, Vol. 58, Iss. 1, 2000-01 ,pp. : 3-7

Karger

Access to resources Recommend Favorite

Quality-adjusted survival analysis of first-line treatment of hormone-receptor-positive HER2++ metastatic breast cancer with letrozole alone or in combination with lapatinib

By Sherrill Beth   Sherif Bintu   Amonkar Mayur M.   Maltzman Julie   O’Rourke Lisa   Johnston Stephen  

Current Medical Research and Opinion, Vol. 27, Iss. 12, 2011-12 ,pp. : 2245-2252

Informa Healthcare

Access to resources Recommend Favorite

Second-Line Chemotherapy of Advanced Disseminated Gastric Cancer after Cisplatin, Infusional 5-Fluorouracil, Folinic Acid (PLF): Benefit Dependant on Progression-Free Interval after First-Line Therapy

By  

Oncology Research and Treatment, Vol. 28, Iss. 10, 2005-09 ,pp. : 499-502

Karger

Access to resources Recommend Favorite

Letrozole: advancing hormone therapy in breast cancer

By Lee Rebecca J   Armstrong Anne C   Wardley Andrew M  

Women's Health, Vol. 8, Iss. 6, 2012-11 ,pp. : 611-618

Future Medicine

Access to resources Recommend Favorite